Lars Thomander

Corporate Officer/Principal at

University of Uppsala

79 year

34 connections

Health Technology

Consumer Services

Commercial Services

Profile

Lars Thomander is the founder of Hlt Konsult AB. He is currently an Associate Professor at the University of Uppsala.
Previously, he worked as the Chairman of CaptiGel AB, Medical Director-Nordic Region at Eli Lilly & Co., Medical Director at Abbott Scandinavia AB, Director at the Foundation for Pharmaceutical Medicine, Medical Director at AbbVie AB, Director at Double Bond Pharmaceutical International AB, and President of the Swedish Pharmaceutical Society.

Lars Thomander active positions

Companies	Position	Start
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-

All active positions of Lars Thomander

Former positions of Lars Thomander

Companies	Position	End
Abbott Scandinavia AB Abbott Scandinavia AB Abbott Scandinavia AB provides information on Rybelsus, the first approved oral GLP-1 receptor agonist containing semaglutide, used to treat adults with type 2 diabetes when diet and exercise alone are insufficient to control blood sugar levels. Abbott Scandinavia focuses on diabetes care and weight management, providing educational resources to patients and healthcare providers about Rybelsus’s benefits, risks, and practical considerations. The company is based in Solna, Sweden. Rybelsus works by mimicking a gut hormone to increase insulin secretion and reduce glucagon, thereby lowering blood sugar, and has also been shown to support weight loss when combined with lifestyle changes. The Swedish company ’ s content highlights the medication ’ s dosing regimen, potential side effects, precautions, and alternatives such as injectable semaglutide products.	Chief Tech/Sci/R&D Officer	2012-12-31
AbbVie AB AbbVie AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical research and development pharmaceutical company	Chief Tech/Sci/R&D Officer	2012-12-31
ELI LILLY AND COMPANY	Chief Tech/Sci/R&D Officer	-
Foundation for Pharmaceutical Medicine	Director/Board Member	-
Swedish Pharmaceutical Society	President	-

See the detail of Lars Thomander's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lars Thomander's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Eli Lilly & Co. Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products	Health Technology
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
CaptiGel AB CaptiGel AB BiotechnologyHealth Technology Provides patented technological platform	Health Technology
Abbott Scandinavia AB Abbott Scandinavia AB Abbott Scandinavia AB provides information on Rybelsus, the first approved oral GLP-1 receptor agonist containing semaglutide, used to treat adults with type 2 diabetes when diet and exercise alone are insufficient to control blood sugar levels. Abbott Scandinavia focuses on diabetes care and weight management, providing educational resources to patients and healthcare providers about Rybelsus’s benefits, risks, and practical considerations. The company is based in Solna, Sweden. Rybelsus works by mimicking a gut hormone to increase insulin secretion and reduce glucagon, thereby lowering blood sugar, and has also been shown to support weight loss when combined with lifestyle changes. The Swedish company ’ s content highlights the medication ’ s dosing regimen, potential side effects, precautions, and alternatives such as injectable semaglutide products.
Foundation for Pharmaceutical Medicine
Swedish Pharmaceutical Society
AbbVie AB AbbVie AB Miscellaneous Commercial ServicesCommercial Services Operates as a clinical research and development pharmaceutical company	Commercial Services
Double Bond Pharmaceutical International AB Double Bond Pharmaceutical International AB BiotechnologyHealth Technology Develops biotechnology products	Health Technology
Hlt Konsult AB